Astrazeneca Ab Drug Patent Portfolio

Astrazeneca Ab's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Alteogen is enhancing its presence in the international biotechnology sector through innovative platform technology that transforms i...

08 Mar, 2026

Leading Pharmaceutical Firms Accelerate Development of Weight-Loss Medications Amid Market Changes

06 Mar, 2026

Generate Biomedicines Raises $400 Million Through IPO to Fund Critical Trials for Severe Asthma Treatment

27 Feb, 2026

Sanofi Appoints Belen Garijo as New CEO, Succeeding Paul Hudson Due to Challenges in Vaccine Sector

13 Feb, 2026